Gilead prices coronavirus drug at US$2,340 for rich countries
Published
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge US$2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.
Full Article